N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide

C126H127F9N30O17S3 — CID 160752856

IUPACN-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide
SMILESCc1cc(-c2ccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)(F)C3)o2)ccn1.Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)(F)C3)cs2)ccn1.Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)C3)cs2)ccn1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCCC(F)(F)C1)c1ccc(-c2cn[nH]c2)o1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCCC(F)(F)C1)c1csc(-c2cn[nH]c2)n1
InChIInChI=1S/C27H27F2N5O4.C26H26F2N6O3S.C26H27FN6O3S.C24H24F2N6O4.C23H23F2N7O3S/c1-17-13-18(5-7-30-17)22-3-4-23(37-22)25(35)31-19-15-24-20(32-26(38-24)33-9-11-36-12-10-33)14-21(19)34-8-2-6-27(28,29)16-34;1-16-11-17(3-5-29-16)24-31-20(14-38-24)23(35)30-18-13-22-19(32-25(37-22)33-7-9-36-10-8-33)12-21(18)34-6-2-4-26(27,28)15-34;1-16-11-17(4-5-28-16)25-30-21(15-37-25)24(34)29-19-13-23-20(12-22(19)33-6-2-3-18(27)14-33)31-26(36-23)32-7-9-35-10-8-32;25-24(26)4-1-5-32(14-24)18-10-17-21(36-23(30-17)31-6-8-34-9-7-31)11-16(18)29-22(33)20-3-2-19(35-20)15-12-27-28-13-15;24-23(25)2-1-3-32(13-23)18-8-16-19(35-22(30-16)31-4-6-34-7-5-31)9-15(18)28-20(33)17-12-36-21(29-17)14-10-26-27-11-14/h3-5,7,13-15H,2,6,8-12,16H2,1H3,(H,31,35);3,5,11-14H,2,4,6-10,15H2,1H3,(H,30,35);4-5,11-13,15,18H,2-3,6-10,14H2,1H3,(H,29,34);2-3,10-13H,1,4-9,14H2,(H,27,28)(H,29,33);8-12H,1-7,13H2,(H,26,27)(H,28,33)
InChIKeyRXBAHFDKWGSUKQ-UHFFFAOYSA-N
MW2600.78 g/mol
LogP22.91
Rot. Bonds25

About N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide

N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide (PubChem CID 160752856) has the molecular formula C126H127F9N30O17S3 and a molecular weight of 2600.78 g/mol. Its IUPAC name is N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide.

Molecular Properties

Compound NameN-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide
PubChem CID160752856
Molecular FormulaC126H127F9N30O17S3
Molecular Weight2600.78 g/mol
Exact Mass2598.90
IUPAC NameN-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide
SMILESCc1cc(-c2ccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)(F)C3)o2)ccn1.Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)(F)C3)cs2)ccn1.Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)C3)cs2)ccn1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCCC(F)(F)C1)c1ccc(-c2cn[nH]c2)o1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCCC(F)(F)C1)c1csc(-c2cn[nH]c2)n1
InChIInChI=1S/C27H27F2N5O4.C26H26F2N6O3S.C26H27FN6O3S.C24H24F2N6O4.C23H23F2N7O3S/c1-17-13-18(5-7-30-17)22-3-4-23(37-22)25(35)31-19-15-24-20(32-26(38-24)33-9-11-36-12-10-33)14-21(19)34-8-2-6-27(28,29)16-34;1-16-11-17(3-5-29-16)24-31-20(14-38-24)23(35)30-18-13-22-19(32-25(37-22)33-7-9-36-10-8-33)12-21(18)34-6-2-4-26(27,28)15-34;1-16-11-17(4-5-28-16)25-30-21(15-37-25)24(34)29-19-13-23-20(12-22(19)33-6-2-3-18(27)14-33)31-26(36-23)32-7-9-35-10-8-32;25-24(26)4-1-5-32(14-24)18-10-17-21(36-23(30-17)31-6-8-34-9-7-31)11-16(18)29-22(33)20-3-2-19(35-20)15-12-27-28-13-15;24-23(25)2-1-3-32(13-23)18-8-16-19(35-22(30-16)31-4-6-34-7-5-31)9-15(18)28-20(33)17-12-36-21(29-17)14-10-26-27-11-14/h3-5,7,13-15H,2,6,8-12,16H2,1H3,(H,31,35);3,5,11-14H,2,4,6-10,15H2,1H3,(H,30,35);4-5,11-13,15,18H,2-3,6-10,14H2,1H3,(H,29,34);2-3,10-13H,1,4-9,14H2,(H,27,28)(H,29,33);8-12H,1-7,13H2,(H,26,27)(H,28,33)
InChIKeyRXBAHFDKWGSUKQ-UHFFFAOYSA-N
XLogP22.91
TPSA515.18 Ų
H-Bond Donors7
H-Bond Acceptors43
Rotatable Bonds25
Heavy Atoms185
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002600.78
LogP ≤ 522.91
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1043

Analyze N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide?
The IUPAC name of N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide (CID 160752856) is N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide.
What is the SMILES notation for N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide?
The canonical SMILES for N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide is Cc1cc(-c2ccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)(F)C3)o2)ccn1.Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)(F)C3)cs2)ccn1.Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCC(F)C3)cs2)ccn1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCCC(F)(F)C1)c1ccc(-c2cn[nH]c2)o1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCCC(F)(F)C1)c1csc(-c2cn[nH]c2)n1.
What is the InChIKey of N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide?
The InChIKey is RXBAHFDKWGSUKQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H27F2N5O4.C26H26F2N6O3S.C26H27FN6O3S.C24H24F2N6O4.C23H23F2N7O3S/c1-17-13-18(5-7-30-17)22-3-4-23(37-22)25(35)31-19-15-24-20(32-26(38-24)33-9-11-36-12-10-33)14-21(19)34-8-2-6-27(28,29)16-34;1-16-11-17(3-5-29-16)24-31-20(14-38-24)23(35)30-18-13-22-19(32-25(37-22)33-7-9-36-10-8-33)12-21(18)34-6-2-4-26(27,28)15-34;1-16-11-17(4-5-28-16)25-30-21(15-37-25)24(34)29-19-13-23-20(12-22(19)33-6-2-3-18(27)14-33)31-26(36-23)32-7-9-35-10-8-32;25-24(26)4-1-5-32(14-24)18-10-17-21(36-23(30-17)31-6-8-34-9-7-31)11-16(18)29-22(33)20-3-2-19(35-20)15-12-27-28-13-15;24-23(25)2-1-3-32(13-23)18-8-16-19(35-22(30-16)31-4-6-34-7-5-31)9-15(18)28-20(33)17-12-36-21(29-17)14-10-26-27-11-14/h3-5,7,13-15H,2,6,8-12,16H2,1H3,(H,31,35);3,5,11-14H,2,4,6-10,15H2,1H3,(H,30,35);4-5,11-13,15,18H,2-3,6-10,14H2,1H3,(H,29,34);2-3,10-13H,1,4-9,14H2,(H,27,28)(H,29,33);8-12H,1-7,13H2,(H,26,27)(H,28,33).
What are the key properties of N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide?
N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide has a molecular weight of 2600.78 g/mol, XLogP of 22.91, 25 rotatable bonds, 7 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(3,3-difluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[5-(3-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide is sourced from PubChem (CID 160752856), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).